Skinvisible, Inc.
SKVI
$0.20
-$0.23-53.69%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| SG&A Expenses | 458.70K | 482.10K | 496.10K | 580.70K | 598.80K |
| Depreciation & Amortization | 20.20K | 20.30K | 20.20K | 20.20K | 21.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 479.00K | 502.40K | 516.40K | 600.90K | 619.80K |
| Operating Income | -459.00K | -482.40K | -496.40K | -580.90K | -599.80K |
| Income Before Tax | -1.03M | -1.05M | -1.06M | -490.80K | -527.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.03 | -1.05 | -1.06 | -0.49 | -0.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03M | -1.05M | -1.06M | -490.80K | -527.20K |
| EBIT | -459.00K | -482.40K | -496.40K | -580.90K | -599.80K |
| EBITDA | -438.70K | -462.10K | -476.10K | -560.70K | -578.80K |
| EPS Basic | -0.19 | -0.19 | -0.20 | -0.10 | -0.12 |
| Normalized Basic EPS | -0.12 | -0.12 | -0.12 | -0.06 | -0.07 |
| EPS Diluted | -0.19 | -0.19 | -0.20 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.12 | -0.12 | -0.12 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 21.62M | 21.62M | 21.57M | 22.80M | 21.93M |
| Average Diluted Shares Outstanding | 21.62M | 21.62M | 21.57M | 22.80M | 21.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |